Integer Holdings Corporation will exhibit innovations in neuromodulation at the NANS Annual Meeting in Orlando, Florida.
Quiver AI Summary
Integer Holdings Corporation will participate in the North American Neuromodulation Society Annual Meeting in Orlando, Florida, from January 30 to February 1, 2025, showcasing its advancements in neuromodulation and miniaturized active implantable medical devices (AIMDs). Attendees at booth #213 can learn how Integer can help accelerate innovation and speed up market entry for medical device companies. The company emphasizes its expertise in implantable technologies, such as its Xcellion® Gen 3 Fast Charge Lithium Ion battery, which offers quick recharging and extended runtime. Integer aims to support the development of next-generation therapies and enhance patient care globally.
Potential Positives
- Integer Holdings Corporation will showcase its innovations in neuromodulation at a prominent industry event, enhancing its visibility and reputation among industry leaders and potential clients.
- The company highlights its expertise in miniaturized active implantable medical devices (AIMDs), positioning itself as a leader in technology that could drive future advancements in medical therapies.
- Integer’s Xcellion® Gen 3 Fast Charge Lithium Ion implantable battery technology offers best-in-class performance, which could attract interest from OEMs seeking to improve their products' efficiency and market competitiveness.
Potential Negatives
- The press release does not provide any financial performance data or growth metrics, which may raise concerns among investors about the company's current market position and future prospects.
- The announcement primarily focuses on showcasing new technologies, which could imply that the company is trying to shift attention away from potential underlying issues or challenges it may be facing in its existing product lines or market competitiveness.
FAQ
What event is Integer Holdings Corporation attending?
Integer Holdings Corporation is attending the NANS Annual Meeting in Orlando, Florida, from Jan. 30 – Feb. 1, 2025.
Where can attendees find Integer at the conference?
Attendees can visit Integer at booth #213 to learn about their innovations and capabilities in neuromodulation.
What technologies will Integer showcase at NANS?
Integer will showcase its latest innovations in miniaturized active implantable medical devices and the Xcellion® Gen 3 Fast Charge battery technology.
What is the significance of Integer's Xcellion Gen 3 battery?
The Xcellion Gen 3 battery offers best-in-class runtime and can be fully recharged in as little as 30 minutes.
How does Integer support medical device companies?
Integer serves as a strategic partner, enhancing innovations and accelerating the path to market for novel implantable medical devices.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ITGR Insider Trading Activity
$ITGR insiders have traded $ITGR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ITGR stock by insiders over the last 6 months:
- JEAN M. HOBBY has made 0 purchases and 2 sales selling 11,960 shares for an estimated $1,431,132.
- MARTIN C MAXWELL sold 4,700 shares for an estimated $558,724
- JOHN A HARRIS (EVP, Global Ops and Manufactur) sold 3,400 shares for an estimated $420,920
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ITGR Hedge Fund Activity
We have seen 153 institutional investors add shares of $ITGR stock to their portfolio, and 146 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 949,134 shares (+355.8%) to their portfolio in Q3 2024, for an estimated $123,387,420
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 834,405 shares (-50.6%) from their portfolio in Q3 2024, for an estimated $108,472,650
- AMERICAN CENTURY COMPANIES INC added 415,604 shares (+2645.5%) to their portfolio in Q3 2024, for an estimated $54,028,520
- FULLER & THALER ASSET MANAGEMENT, INC. removed 310,110 shares (-24.0%) from their portfolio in Q3 2024, for an estimated $40,314,300
- FRANKLIN RESOURCES INC removed 298,752 shares (-31.3%) from their portfolio in Q3 2024, for an estimated $38,837,760
- ORBIMED ADVISORS LLC added 225,779 shares (+64.7%) to their portfolio in Q3 2024, for an estimated $29,351,270
- AMERIPRISE FINANCIAL INC added 216,311 shares (+24.8%) to their portfolio in Q3 2024, for an estimated $28,120,430
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Orlando, Florida, from Jan. 30 – Feb. 1, 2025.
NANS attendees are invited to visit booth #213 to learn more about how Integer can serve as a strategic partner of choice in amplifying customers’ innovation and increasing speed to market. More specifically, Integer will showcase its latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable medical devices (AIMDs).
“Through miniaturization, Integer is creating the next generation of differentiated platform technologies to accelerate and de-risk OEMs’ path to market for novel implantable medical devices,” said Jim Stephens, President, Cardiac Rhythm Management & Neuromodulation. “Our broad expertise in critical implantable technologies—from batteries to fully integrated implantable pulse generator systems—uniquely positions Integer to deliver advancements in miniaturized AIMD technologies and help enable our customers’ future therapies. We look forward to discussing this and more at NANS.”
During NANS, attendees can also learn more about Integer’s Xcellion ® Gen 3 Fast Charge (FC) Lithium Ion implantable battery technology. Xcellion Gen 3 FC delivers best in class battery runtime and full re-charges in as little as 30 minutes.
Learn more about Integer at www.integer.net .
About Integer
®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical
®
and Lake Region Medical
®
. Additional information is available at
www.integer.net
.
Investor Relations: | Media Relations: |
Andrew Senn | Kelly Butler |
[email protected] | [email protected] |
763.951.8312 | 469.731.6617 |